查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790479

个人化医疗市场规模、份额和趋势分析报告：按产品、最终用途、地区和细分市场预测，2025 年至 2033 年

Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

个人化医疗市场概况

2024年全球个人化医疗市场规模估计为5,671亿美元，预计2033年将达到1,1961.8亿美元，2025年至2033年的复合年增长率为8.80%。对标靶治疗和精准诊断的需求不断增长，大大推动了个人化医疗市场的扩张。

基因组技术、生物标记识别和数据驱动治疗策略的进步使医疗保健提供者能够根据患者的个别情况量身定制治疗方案。这种方法可以提高治疗效果，最大限度地减少副作用，并支持高效利用医疗资源。随着全球慢性病和复杂疾病的增多，对个人化解决方案的关注度持续上升，推动了诊断、治疗和健康数据整合平台的创新和投资。癌症、糖尿病和心血管疾病等慢性病的发生率上升，促使医疗保健提供者实施个人化治疗策略。

个人化诊断提高了疾病识别的准确性，从而实现早期疗育并改善临床疗效。 2024年，Illumina公司获得FDA核准的TruSight Oncology综合检测分析了500多个基因，用于指南癌症的标靶治疗。患者对遗传易感性的认识不断提高，这推动了基于DNA的检测服务的广泛应用。这种积极主动、针对患者的照护模式的趋势，将继续扩大医疗保健领域各个领域的市场潜力。

基因组学、人工智慧和数据分析领域的技术进步进一步推动了个人化医疗市场的成长。各公司正在利用次世代定序仪、生物标记发现和生物资讯学，开发针对个别患者特征的创新解决方案。人工智慧与临床决策的整合，使得快速分析复杂数据集成为可能，从而提高诊断准确性并丰富治疗方法方案。远端医疗平台和医疗IT系统促进了个人化医疗的远距访问，尤其是在慢性病管理方面。这些技术创新正在再形成医疗服务，并支持客製化方案的可扩展应用。

私部门投资和策略联盟的不断增加也促进了市场发展势头。製药公司正在与诊断公司合作，共同开发用于标靶治疗的伴随诊断。新兴企业和生物技术公司正凭藉创新的营养、健康和基因组学产品进入市场。消费者对健康优化和预防保健日益增长的兴趣，推动了直接面向消费者的检测和客製化健康计划的需求。为了更好地参与市场竞争，各公司正专注于产品差异化、数据主导策略和全球扩张。

目录

第一章调查方法与范围

第二章执行摘要

第三章：个人化医疗市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 专利到期分析
    • 定价分析

第四章：个人化医疗市场：产品业务分析

  • 2024年及2033年的产品市场占有率
  • 产品细分仪表板
  • 市场规模、预测与趋势分析（按产品，2021-2033 年）
  • 个性化医疗诊断
  • 个人化医疗
  • 个人化医疗
  • 个人化营养与健康

5.个人化医疗市场：最终用途业务分析

  • 2024年和2033年的最终用途市场占有率
  • 最终用途细分仪表板
  • 按最终用途分類的市场规模、预测和趋势分析（2021-2033 年）
  • 医院
  • 诊断中心
  • 研究和学术机构
  • 其他的

第六章：个人化医疗市场：区域、估计与趋势分析

  • 2024 年及 2033 年区域市场占有率分析
  • 区域市场仪表板
  • 2021-2033年市场规模与预测趋势分析
  • 北美洲
    • 按国家/地区，2021-2033 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 参与者概览
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • GE Healthcare
    • Illumina, Inc.
    • ASURAGEN, INC.
    • Abbott
    • Dako A/S
    • Exact Sciences Corporation
    • Danaher Corporation（Cepheid, Inc.）
    • Decode Genetics, Inc.
    • QIAGEN
    • Exagen Inc.
    • Precision Biologics
    • Celera Diagnostics LLC.
    • Biogen
    • Genelex
    • International Business Machines Corporation（IBM）
    • Genentech, Inc.
Product Code: 978-1-68038-443-7

Personalized Medicine Market Summary

The global personalized medicine market size was estimated at USD 567.10 billion in 2024 and is projected to reach USD 1,196.18 billion by 2033, growing at a CAGR of 8.80% from 2025 to 2033. The growing demand for targeted therapies and precision diagnostics is significantly driving the expansion of the personalized medicine market.

Advances in genomic technologies, biomarker identification, and data-driven treatment strategies enable healthcare providers to tailor therapies to individual patient profiles. This approach enhances treatment efficacy, minimizes adverse effects, and supports more efficient use of healthcare resources. As chronic and complex diseases rise globally, the focus on personalized solutions continues to strengthen, fostering innovation and investment across diagnostics, therapeutics, and health data integration platforms. The rise in chronic conditions such as cancer, diabetes, and cardiovascular diseases is prompting healthcare providers to implement individualized treatment strategies.

Personalized diagnostics deliver greater accuracy in disease identification, leading to earlier intervention and better clinical outcomes. Personalized diagnostics delivered greater accuracy in disease identification, as in 2024 when Illumina's FDA approved TruSight Oncology Comprehensive test analyzed over 500 genes to guide targeted cancer treatments. The increasing awareness among patients of genetic predispositions supports the uptake of DNA-based testing services. This movement toward proactive, patient-specific care models continues to expand the market's potential across medical domains.

Technological advancements in genomics, artificial intelligence, and data analytics further fuel growth in the personalized medicine market. Companies are leveraging next-generation sequencing, biomarker discovery, and bioinformatics to develop innovative solutions tailored to individual patient profiles. AI integration into clinical decision-making is enabling faster analysis of complex datasets, enhancing diagnostic precision and therapy selection. Telemedicine platforms and health IT systems facilitate remote access to personalized care, especially in chronic disease management. These technological innovations are reshaping healthcare delivery and supporting the scalable adoption of customized approaches.

Increasing private sector investments and strategic collaborations are also contributing to market momentum. Pharmaceutical companies are partnering with diagnostics firms to co-develop companion diagnostics for targeted therapies. Startups and biotech firms are entering the market with innovative nutrition, wellness, and genomics offerings. Expanding consumer interest in health optimization and preventive care is boosting demand for direct-to-consumer testing and customized wellness plans. Market players focus on product differentiation, data-driven strategies, and global expansion to strengthen their competitive positions.

Global Personalized Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global personalized medicine market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Personalized Medicine Diagnostics
    • Genetic Testing
    • Direct-To-Consumer (DTC) Diagnostics
    • Esoteric Lab Services
    • Esoteric Lab Tests
  • Personalized Medicine Therapeutics
    • Pharmaceutical
    • Genomic Medicine
    • Medical Devices
  • Personalized Medical Care
    • Telemedicine
    • Health Information Technology
  • Personalized Nutrition & Wellness
    • Retail Nutrition
    • Complementary & Alternative Medicine
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Centers
  • Research & Academic Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Personalized Medicine Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Personalized Medicine Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Personalized Medicine Diagnostics
    • 4.4.1. Personalized Medicine Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.4.2. Genetic Testing
      • 4.4.2.1. Genetic Testing Market, 2021 - 2033 (USD Million)
    • 4.4.3. Direct-To-Consumer (DTC) Diagnostics
      • 4.4.3.1. Direct-To-Consumer (DTC) Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.4.4. Esoteric Lab Services
      • 4.4.4.1. Esoteric Lab Services Market, 2021 - 2033 (USD Million)
    • 4.4.5. Esoteric Lab Tests
      • 4.4.5.1. Esoteric Lab Tests Market, 2021 - 2033 (USD Million)
  • 4.5. Personalized Medicine Therapeutics
    • 4.5.1. Personalized Medicine Therapeutics Market, 2021 - 2033 (USD Million)
    • 4.5.2. Pharmaceutical
      • 4.5.2.1. Pharmaceutical Market, 2021 - 2033 (USD Million)
    • 4.5.3. Genomic Medicine
      • 4.5.3.1. Genomic Medicine Market, 2021 - 2033 (USD Million)
    • 4.5.4. Medical Devices
      • 4.5.4.1. Medical Devices Market, 2021 - 2033 (USD Million)
  • 4.6. Personalized Medical Care
    • 4.6.1. Personalized Medical Care Market, 2021 - 2033 (USD Million)
    • 4.6.2. Telemedicine
      • 4.6.2.1. Telemedicine Market, 2021 - 2033 (USD Million)
    • 4.6.3. Health Information Technology
      • 4.6.3.1. Health Information Technology Market, 2021 - 2033 (USD Million)
  • 4.7. Personalized Nutrition & Wellness
    • 4.7.1. Personalized Nutrition & Wellness Market, 2021 - 2033 (USD Million)
    • 4.7.2. Retail Nutrition
      • 4.7.2.1. Retail Nutrition Market, 2021 - 2033 (USD Million)
    • 4.7.3. Complementary & Alternative Medicine
      • 4.7.3.1. Complementary & Alternative Medicine Market, 2021 - 2033 (USD Million)

Chapter 5. Personalized Medicine Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2033
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals Market, 2021 - 2033 (USD Million)
  • 5.5. Diagnostic Centers
    • 5.5.1. Diagnostic Centers Market, 2021 - 2033 (USD Million)
  • 5.6. Research & Academic Institutes
    • 5.6.1. Research & Academic Institutes Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Personalized Medicine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Personalized Medicine Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. End Use Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. End Use Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. End Use Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. End Use Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. End Use Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. End Use Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. End Use Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. End Use Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. End Use Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. End Use Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. End Use Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. End Use Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. End Use Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. End Use Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. End Use Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. End Use Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. End Use Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. End Use Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. End Use Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. End Use Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. End Use Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. End Use Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. End Use Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. GE Healthcare
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Illumina, Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. ASURAGEN, INC.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Abbott
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Dako A/S
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Exact Sciences Corporation
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Danaher Corporation (Cepheid, Inc.)
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Decode Genetics, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. QIAGEN
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Exagen Inc.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Precision Biologics
      • 7.5.11.1. Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. Celera Diagnostics LLC.
      • 7.5.12.1. Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
    • 7.5.13. Biogen
      • 7.5.13.1. Overview
      • 7.5.13.2. Financial Performance
      • 7.5.13.3. Product Benchmarking
    • 7.5.14. Genelex
      • 7.5.14.1. Overview
      • 7.5.14.2. Financial Performance
      • 7.5.14.3. Product Benchmarking
    • 7.5.15. International Business Machines Corporation (IBM)
      • 7.5.15.1. Overview
      • 7.5.15.2. Financial Performance
      • 7.5.15.3. Product Benchmarking
    • 7.5.16. Genentech, Inc.
      • 7.5.16.1. Overview
      • 7.5.16.2. Financial Performance
      • 7.5.16.3. Product Benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Personalized medicine market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America Personalized medicine market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 9 U.S. Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 10 U.S. Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 11 Canada Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 12 Canada Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Mexico Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 14 Mexico Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 15 Europe Personalized medicine market, by country, 2021 - 2033 (USD Million)
  • Table 16 Europe Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 17 Europe Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 18 UK Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 19 UK Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Germany Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 21 Germany Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 22 France Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 23 France Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Italy Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 25 Italy Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Spain Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 27 Spain Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Norway Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 29 Norway Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Denmark Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 31 Denmark Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Sweden Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 33 Sweden Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Personalized medicine market, by country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Personalized medicine market, by product, 2021 - 2033 (USD
  • Table 36 Asia Pacific Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Japan Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 38 Japan Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 39 China Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 40 China Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 41 India Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 42 India Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Australia Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 44 Australia Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 45 South Korea Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 46 South Korea Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Thailand Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 48 Thailand Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Latin America Personalized medicine market, by country, 2021 - 2033 (USD Million)
  • Table 50 Latin America Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 51 Latin America Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Brazil Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 53 Brazil Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Argentina Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 55 Argentina Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa Personalized medicine market, by country, 2021 - 2033 (USD Million)
  • Table 57 Middle East & Africa Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 58 Middle East & Africa Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 59 South Africa Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 60 South Africa Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 63 UAE Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 64 UAE Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Kuwait Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 66 Kuwait Personalized medicine market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Personalized medicine market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Personalized medicine market dynamics
  • Fig. 12 Personalized medicine market: Porter's five forces analysis
  • Fig. 13 Personalized medicine market: PESTLE analysis
  • Fig. 14 Product market, 2021 - 2033 (USD Million)
  • Fig. 15 Personalized medicine diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 16 Genetic testing market, 2021 - 2033 (USD Million)
  • Fig. 17 Direct-To-Consumer (DTC) Diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 18 Esoteric lab services market, 2021 - 2033 (USD Million)
  • Fig. 19 Esoteric lab tests market, 2021 - 2033 (USD Million)
  • Fig. 20 Personalized medicine therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 21 Pharmaceutical market, 2021 - 2033 (USD Million)
  • Fig. 22 Genomic medicine market, 2021 - 2033 (USD Million)
  • Fig. 23 Medical devices market, 2021 - 2033 (USD Million)
  • Fig. 24 Personalized medical care market, 2021 - 2033 (USD Million)
  • Fig. 25 Telemedicine market, 2021 - 2033 (USD Million)
  • Fig. 26 Health information technology market, 2021 - 2033 (USD Million)
  • Fig. 27 Personalized nutrition & wellness market, 2021 - 2033 (USD Million)
  • Fig. 28 Retail nutrition market, 2021 - 2033 (USD Million)
  • Fig. 29 Complementary & alternative medicine market, 2021 - 2033 (USD Million)
  • Fig. 30 End use market, 2021 - 2033 (USD Million)
  • Fig. 31 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 32 Diagnostic centers market, 2021 - 2033 (USD Million)
  • Fig. 33 Research & academic institutes market, 2021 - 2033 (USD Million)
  • Fig. 34 Others market, 2021 - 2033 (USD Million)
  • Fig. 35 Personalized medicine market revenue, by region
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 North America Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. country dynamics
  • Fig. 39 U.S. Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 40 Canada country dynamics
  • Fig. 41 Canada Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico country dynamics
  • Fig. 43 Mexico Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 45 UK country dynamics
  • Fig. 46 UK Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 47 Germany country dynamics
  • Fig. 48 Germany Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 49 France country dynamics
  • Fig. 50 France Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 51 Italy country dynamics
  • Fig. 52 Italy Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 53 Spain country dynamics
  • Fig. 54 Spain Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 55 Norway country dynamics
  • Fig. 56 Norway Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 57 Sweden country dynamics
  • Fig. 58 Sweden Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 59 Denmark country dynamics
  • Fig. 60 Denmark Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 61 Asia Pacific Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 62 Japan country dynamics
  • Fig. 63 Japan Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 64 China country dynamics
  • Fig. 65 China Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 66 India country dynamics
  • Fig. 67 India Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 68 Australia country dynamics
  • Fig. 69 Australia Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 70 South Korea country dynamics
  • Fig. 71 South Korea Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 72 Thailand country dynamics
  • Fig. 73 Thailand Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 74 Latin America Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 75 Brazil country dynamics
  • Fig. 76 Brazil Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 77 Argentina country dynamics
  • Fig. 78 Argentina Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 79 MEA Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 80 South Africa country dynamics
  • Fig. 81 South Africa Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 82 Saudi Arabia country dynamics
  • Fig. 83 Saudi Arabia Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 84 UAE country dynamics
  • Fig. 85 UAE Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 86 Kuwait country dynamics
  • Fig. 87 Kuwait Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 88 Company categorization
  • Fig. 89 Company market position analysis
  • Fig. 90 Strategic framework